Pharmaceutical Business review

Anesiva prices common stock offering

The underwriters have agreed to purchase the shares from Anesiva pursuant to an underwriting agreement. Anesiva has granted the underwriters the option to purchase up to an additional 1.2 million shares of common stock to cover over-allotments, if any. The offering is expected to close on December 18, 2007, subject to customary closing conditions.

Pacific Growth Equities, Broadpoint Capital and Fortis Securities are acting as underwriters for this offering.